Trials in Medicine

Mexico City, Mexico City 06700

1 studies enrolling now · 3 studies all time

What they study most

Active Nonsegmental Vitiligo, Atopic Dermatitis, Eczema, Stable Nonsegmental Vitiligo

Studies at this site

• A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Enrolling by invitation
• A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2 — Running, not enrolling
• A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis — Stopped early